Fineline Cube

Follow:
14855 Articles
InnoCare Doses First Patient in Registrational Phase III Head‑to‑Head Trial of Mesutoclax Versus Venetoclax – Challenging the Standard of Care in Treatment‑Naïve AML
CompanyDrug

InnoCare Doses First Patient in Registrational Phase III Head‑to‑Head Trial of Mesutoclax Versus Venetoclax – Challenging the Standard of Care in Treatment‑Naïve AML

RonGu Biotechnology Completes Series A Financing of Nearly RMB 100 Million – Advancing Off‑the‑Shelf CAR‑NK and CAR‑T Therapies for Systemic Lupus Erythematosus
CompanyDeals

RonGu Biotechnology Completes Series A Financing of Nearly RMB 100 Million – Advancing Off‑the‑Shelf CAR‑NK and CAR‑T Therapies for Systemic Lupus Erythematosus

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer's Disease Diagnosis and Treatment
CompanyDeals

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer’s Disease Diagnosis and Treatment

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform
CompanyDeals

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion
Company

Viatris Reports Stable Q3 2026 Results with Enhanced Profitability – Raises Full‑Year Guidance as Pacira BioSciences Acquisition Nears Completion

Boehringer Ingelheim and Ruijin Hospital Launch "China Bronchiectasis Care Action" at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management
CompanyDeals

Boehringer Ingelheim and Ruijin Hospital Launch “China Bronchiectasis Care Action” at CIIE – Advancing Standardized Diagnosis and Long‑Term Disease Management

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies
CompanyDeals

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy
CompanyDeals

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology
CompanyDeals

Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology

Hangzhou Diagens Forges Strategic Partnership with Yongjiang Laboratory – Deploying Medical Imaging Large Models Across Guangxi and ASEAN
CompanyDeals

Hangzhou Diagens Forges Strategic Partnership with Yongjiang Laboratory – Deploying Medical Imaging Large Models Across Guangxi and ASEAN

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody
CompanyDeals

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program
CompanyDeals

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program